Patents by Inventor Nicole Villeneuve

Nicole Villeneuve has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5565457
    Abstract: The compounds are N-(2,3,4-trimethoxybenzyl)piperazines N'-substituted by a radical containing a sulfonamide group, and pharmaceutically tolerable salts thereof, useful for treating myocardial ischaemic pathologies, cerebral vascular accident and manifestations of deficiency associated with chronic cerebral circulatory disorders.A compound disclosed is : N-benzyl-N-{3,3-dimethyl-4-[4-(2,3,4-trimethoxybenzyl) piperazin-1-yl]butyl}-(isoquinolin-5-yl)sulfonamide and its fumarate.
    Type: Grant
    Filed: February 23, 1995
    Date of Patent: October 15, 1996
    Assignee: Adir et Compagnie
    Inventors: Jean-Louis Peglion, Jean-Paul Vilaine, Nicole Villeneuve, Jean-Pierre Iliou, Jean-Pierre Bidouard
  • Patent number: 5298503
    Abstract: Compounds of formula (I): ##STR1## wherein R.sub.1, R.sub.2, U, X, Y, Z, n, m, p and r are as defined in the description, and medicaments containing the same.
    Type: Grant
    Filed: July 30, 1992
    Date of Patent: March 29, 1994
    Assignee: Adir et Compagnie
    Inventors: Jean-Louis Peglion, Jean-Paul Vilaine, Nicole Villeneuve, Philip Janiak
  • Patent number: 5296482
    Abstract: The compounds are 3-[ (benzocycloalkyl)alkyl amino alkyl] -1,3,4,5-te trahydro 2H- 3-benzazepin-2 ones useful in cardiovascular field.A compound disclosed is (R,S)-7,8-dimethoxy-3-{3-{N-[(4,5-dimethoxybenzocyclobut-1-yl) methyl]-N-methyl amino}propyl}-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one.
    Type: Grant
    Filed: September 25, 1992
    Date of Patent: March 22, 1994
    Assignee: Adir et Compagnie
    Inventors: Jean-Louis Peglion, Joel Vian, Jean-Paul Vilaine, Nicole Villeneuve, Philip Janiak, Jean-Pierre Bidouard
  • Patent number: 5283246
    Abstract: The compounds are substituted trimetazidine useful for the treatment of ischaemic pathologies and peripheral vascular pathology.A compound disclosed is 4-(2,3,4-trimethoxybenzyl)-1-[3-(4-hydroxy-2,3,5-trimethylphenoxy)propyl]p iperazine.
    Type: Grant
    Filed: September 17, 1992
    Date of Patent: February 1, 1994
    Assignee: Adir et Compagnie
    Inventors: Gilbert Regnier, Jean-Paul Vilaine, Nicole Villeneuve, Jean-Pierre Bidouard, Jean-Pierre Iliou, Albert Lenaers
  • Patent number: 5208243
    Abstract: Compounds of formula (I): ##STR1## with R.sub.1, R.sub.2, U, X, Y, Z, n, m, p and r as defined in the description.Medicinal products.
    Type: Grant
    Filed: July 30, 1992
    Date of Patent: May 4, 1993
    Assignee: Adir et Compagnie
    Inventors: Jean-Louis Peglion, Jean-Paul Vilaine, Nicole Villeneuve, Philip Janiak
  • Patent number: 4999372
    Abstract: New aminochromanol compounds of the formula: ##STR1## in which X is cyano, nitro, trifluoromethyl, alkoxycarbonyl, carbamido, dialkylcarbamido, aminosulfonyl, dialkylaminosulfonyl, alkylsulfonyl, alkylsulfonylamino or acyl;CH.sub.2 -R is attached (in the 5 position of the pyrrolidinone nucleus) to an R- or S-configured carbon atom, and R is:either OR' or SR' in which R' is hydrogen, (C.sub.1 -C.sub.10)-alkyl, (C.sub.1 -C.sub.5 -alkyl)-carbonyl or ##STR2## and physiologically tolerable acid addition salts thereof, in the case where R contains a basic function.These compounds and their physiologically tolerable salts can be used in therapeutics for the activation of potassium channels, especially in the treatment of disorders associated with abnormal smooth muscle contraction and in the cardiovascular, bronchopulmonary, digestive, urinary and uterine fields.
    Type: Grant
    Filed: October 11, 1989
    Date of Patent: March 12, 1991
    Assignee: ADIR et Compagnie
    Inventors: Gilbert Regnier, Alain Dhainaut, Jean-Paul Vilaine, Nicole Villeneuve, Ghislaine Joly, Jacques Duhault